Suppr超能文献

埃兹蛋白重新分布的细胞间黏附分子-2作为杀伤细胞的靶标。

ICAM-2 redistributed by ezrin as a target for killer cells.

作者信息

Helander T S, Carpén O, Turunen O, Kovanen P E, Vaheri A, Timonen T

机构信息

Department of Pathology, University of Helsinki, Finland.

出版信息

Nature. 1996 Jul 18;382(6588):265-8. doi: 10.1038/382265a0.

Abstract

Very little is known about the receptors and target molecules involved in natural killer (NK) cell activity. Here we present a model system in which interleukin-2-activated killing by NK cells depends on the intercellular adhesion molecule ICAM-2 and is regulated by the distribution of ICAM-2. The level of ICAM-2 expression in NK-sensitive and resistant cells is similar, but in sensitive cells ICAM-2 is concentrated into bud-like cellular projections known as uropods, whereas in resistant cells it is evenly distributed. The cytoskeletal-membrane linker protein ezrin is also localized in uropods. Transfection of human ezrin into NK-resistant cells induces uropods formation, redistribution of ICAM-2 and ezrin, and sensitizes target cells to interleukin-2-activated killing. These results reveal a new mechanism of target-cell recognition: cytotoxic cells recognize adhesion molecules that are already present on normal cells, but in diseased cells are concentrated into a biologically active cell-surface region by cytoskeletal reorganization. The results also highlight the importance of cytoskeletal interactions in the regulation of ICAM-2-mediated adhesive phenomena.

摘要

关于自然杀伤(NK)细胞活性所涉及的受体和靶分子,人们了解甚少。在此,我们展示了一个模型系统,其中NK细胞经白细胞介素-2激活后的杀伤作用依赖于细胞间黏附分子ICAM-2,并受ICAM-2分布的调控。NK敏感细胞和抗性细胞中ICAM-2的表达水平相似,但在敏感细胞中,ICAM-2集中于称为尾足的芽状细胞突起中,而在抗性细胞中它则均匀分布。细胞骨架-膜连接蛋白埃兹蛋白也定位于尾足中。将人埃兹蛋白转染到NK抗性细胞中可诱导尾足形成、ICAM-2和埃兹蛋白的重新分布,并使靶细胞对白细胞介素-2激活的杀伤作用敏感。这些结果揭示了一种新的靶细胞识别机制:细胞毒性细胞识别正常细胞上已存在的黏附分子,但在患病细胞中,这些黏附分子通过细胞骨架重组而集中到具有生物活性的细胞表面区域。这些结果还突出了细胞骨架相互作用在调控ICAM-2介导的黏附现象中的重要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验